PRESS RELEASE published on 08/06/2024 at 09:01, 1 year 8 months ago Original-Research: LAIQON AG (von NuWays AG): BUY LAIQON AG successfully places LAIC token 24 & intensifies cooperation with mVBRB, leading to total gross proceeds of €7.2m. Additional undisclosed payment to be invested in enhancing DAP 4.0 and personnel development Investments Coopération LAIQON AG LAIC Token MVBRB
PRESS RELEASE published on 08/06/2024 at 09:00, 1 year 8 months ago Biotest increases sales in the first half of 2024 by 35% to Euro 372 million Biotest AG reports 35% sales increase to Euro 372 million in H1 2024. EBIT reaches Euro 78.4 million. FDA approves Yimmugo® and BNL facility. Positive revenue and earnings growth Revenue Growth FDA Approval Sales Increase Biotest AG H1 2024
PRESS RELEASE published on 08/06/2024 at 09:00, 1 year 8 months ago Northern Data Group announces Q2 Results, reaffirms 2024 guidance Northern Data Group reports Q2 revenue growth of 22% year-on-year to EUR 26 million, reaffirms 2024 revenue target of EUR 200-240 million, driven by Cloud and HPC infrastructure expansion Revenue Growth Northern Data Group 2024 Guidance Q2 Results HPC Solutions
PRESS RELEASE published on 08/06/2024 at 08:31, 1 year 8 months ago Cherry SE Releases 2024 Half-Year Report Cherry SE releases its 2024 Half-Year Report, showing revenue growth in DIGITAL HEALTH & SOLUTIONS segment and confirmed forecasts for 2024 Revenue Growth Cherry SE Forecasts 2024 Half-Year Report DIGITAL HEALTH & SOLUTIONS
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT, confirmant son avancement vers l'objectif de recrutement complet au premier trimestre 2025 Abivax Recrutement Essai Clinique Phase 3 ABTECT
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT, confirmant l'évolution favorable du projet. La société réaffirme ses prévisions pour 2025 Abivax Recrutement Traitement Phase 3 ABTECT
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone Abivax announces ABTECT Phase 3 Trial surpasses 600-patient enrollment milestone, on track for full enrollment by early Q1 2025. Trial trends align with previous observations Abivax Obefazimod Ulcerative Colitis ABTECT Phase 3 Trial Enrollment Milestone
REGULATED PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 29/07/2024 tot 02/08/2024 Cie du Bois Sauvage voert terugkoop van eigen aandelen uit zoals gemachtigd door de buitengewone algemene vergadering van 28 april 2021 NYSE Euronext Brussel Financiële Informatie Cie Du Bois Sauvage Terugkoop Eigen Aandelen Buitengewone Algemene Vergadering
REGULATED PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Cie du Bois Sauvage : Rachat d’actions propres – semaine du 29/07/2024 au 02/08/2024 La Compagnie du Bois Sauvage annonce le rachat de 655 actions propres sur le marché réglementé NYSE Euronext Bruxelles, conformément à l'autorisation de l'AG du 28/04/2021 Rachat D'actions NYSE Euronext Bruxelles Compagnie Du Bois Sauvage Transactions Actions Propres Autorisation AG
REGULATED PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Cie du Bois Sauvage: Buy back of own shares – week from 29/07/2024 to 02/08/2024 Compagnie du Bois Sauvage announces buy back of own shares from 29/07/2024 to 02/08/2024, totaling €179,277.00. Details available on www.bois-sauvage.be NYSE Euronext Market Brussels Financial Transactions Own Shares Compagnie Du Bois Sauvage Buy Back
Published on 04/23/2026 at 18:00, 47 minutes ago Gold Port Renews Groete Project Mining Permit; Advances Camp Reconstruction
Published on 04/23/2026 at 16:20, 2 hours 27 minutes ago CORRECTION FROM SOURCE: Avino Announces Q1 2026 Production Results
Published on 04/23/2026 at 15:00, 3 hours 47 minutes ago critical elements annonce les résultats de l'assemblée annuelle des actionnaires
Published on 04/23/2026 at 15:00, 3 hours 47 minutes ago Critical Elements Announces the Results from The Annual Meeting of Shareholders
Published on 04/23/2026 at 14:30, 4 hours 17 minutes ago Klondike Gold Engages Fundamental Research Corp. for Analyst Coverage
Published on 04/23/2026 at 18:30, 17 minutes ago Readcrest Capital postpones the publication of its audited consolidated financial statements until mid-May 2026 – Sale of the UK nursing home business requires an adjusted presentation
Published on 04/23/2026 at 18:00, 47 minutes ago Oxford Royale Academy Partners with MIT to Bring AI Education to Summer School Students
Published on 04/23/2026 at 18:00, 47 minutes ago Sales data for the first quarter of 2026: FORVIA HELLA starts the new fiscal year with solid sales performance
Published on 04/23/2026 at 17:45, 1 hour 2 minutes ago Linedata Services: Chiffre d’affaires du T1 2026 : 40,2 M€ (-8,5%)
Published on 04/23/2026 at 18:18, 29 minutes ago Aéroports de Paris SA - Cession par le Groupe ADP à GMR Group de titres représentant 3,4% du capital de GAL, avec une option de cession portant sur 3,9% supplémentaires
Published on 04/23/2026 at 18:18, 29 minutes ago Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
